Utilization of Metabolomics to Identify Serum Biomarkers for Hepatocellular Carcinoma in Patients with Liver Cirrhosis

Characterizing the metabolic changes pertaining to hepatocellular carcinoma (HCC) in patients with liver cirrhosis is believed to contribute towards early detection, treatment, and understanding of the molecular mechanisms of HCC. In this study, we compare metabolite levels in sera of 78 HCC cases w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ressom, Habtom W., Xiao, Jun Feng, Tuli, Leepika, Varghese, Rency S., Zhou, Bin, Tsai, Tsung-Heng, Nezami Ranjbar, Mohammad R., Zhao, Yi, Wang, Jinlian, Di Poto, Cristina, Cheema, Amrita K., Tadesse, Mahlet G., Goldman, Radoslav, Shetty, Kirti
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3419576/
https://ncbi.nlm.nih.gov/pubmed/22882828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.aca.2012.07.013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares